key: cord-0915282-914dlk1d
authors: Aomatsu, Naoki; Shigemitsu, Kazuaki; Nakagawa, Hidenori; Morooka, Takaya; Ishikawa, Junichi; Yamashita, Tomoya; Tsuruoka, Ayumu; Fuke, Akihiro; Motoyama, Koka; Kitagawa, Daiki; Ikeda, Katsumi; Maeda, Kiyoshi; Shirano, Michinori; Rinka, Hiroshi
title: Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit
date: 2021-10-01
journal: Neuropeptides
DOI: 10.1016/j.npep.2021.102201
sha: d9168bd84f457f67ab6bbfd4ef7f914cd2d35278
doc_id: 915282
cord_uid: 914dlk1d

Coronavirus Disease-2019 (COVID-19), an infectious disease associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a global emergency with high mortality. There are few effective treatments, and many severe patients are treated in an intensive care unit (ICU). The purpose of this study was to evaluate whether the Japanese Kampo medicine ninjin'yoeito (NYT) is effective in treating ICU patients with COVID-19. Nine patients with confirmed SARS-CoV-2 infection admitted to the ICU were enrolled in this study. All patients underwent respiratory management with invasive mechanical ventilation (IMV) and enteral nutrition. Four patients received NYT (7.5 g daily) from an elemental diet tube. We retrospectively examined the prognostic nutritional index (PNI), length of IMV, length of ICU stay, length of hospital stay, rate of tracheostomy, and mortality rate. The median age of the enrolled participants was 60.0 years (4 men and 5 women). The median body mass index was 27.6. The most common comorbidity was diabetes (4 patients, 44%), followed by hypertension (3 patients, 33%) and chronic kidney disease (2 patients, 22%). The median length of IMV, ICU stay, and hospital stay were all shorter in the NYT group than in the non-NYT group (IMV; 4.0 days vs 14.3 days, ICU; 5.3 days vs 14.5 days, hospital stay; 19.9 days vs 28.2 days). In the NYT and non-NYT groups, the median PNI at admission was 29.0 and 31.2, respectively. One week after admission, the PNI was 30.7 in the NYT group and 24.4 in non-NYT group. PNI was significantly (p = 0.032) increased in the NYT group (+13.6%) than in the non-NYT group (−22.0%). The Japanese Kampo medicine NYT might be useful for treating patients with severe COVID-19 in ICU. This study was conducted in a small number of cases, and further large clinical trials are necessary.

Coronavirus disease-2019 , first reported in Wuhan, China in December 2019, is rapidly expanding worldwide (Wang et al., 2020b) . It is an infectious disease associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (Perlman, 2020; Zhang et al., 2020) , and has now become a global emergency.

There are few effective treatments, and severe patients are treated in an intensive care unit (ICU). In the ICU, many patients with COVID-19 pneumonia develop severe hypoxemic respiratory failure and require invasive mechanical ventilation (IMV). Based on NIH COVID-19 Treatment Guidelines, patients in some countries may receive remdesivir and dexamethasone (Sanders et al., 2020) . However, cases in ICU are invariably associated with high mortality. The ICU mortality rate reported in previous studies ranges from 16% to 78% (Arentz et al., 2020; Bhatraju et al., 2020; Huang et al., 2020; Myers et al., 2020; Wang et al., 2020a; Wang et al., 2020c; Yang et al., 2020; Zhou et al., 2020) .

Globally, as of 30 August 2021, there have been 214,468,601 confirmed cases of including 4, 470, 969 deaths, reported to WHO (see, https://covid19.who.int).

In Japan, COVID-19 has resulted in 1,388,863 confirmed cases with more than 15,797 deaths. The purpose of this study was to evaluate the effectiveness of NYT in preventing the progression of COVID-19 and shortening the length of stay in the ICU or length of hospital stay. In addition, we aimed to assess the effect of NYT on the prognostic nutritional index (PNI) of patients.

May and June 2021 were enrolled in this study. All patients were diagnosed COVID-19 by a positive result for SARS-CoV-2 RNA in nasopharyngeal swabs using real-time fluorescence reverse transcription-polymerase chain reaction (RT-PCR). All patients received remdesivir and dexamethasone (Sanders et al., 2020) .

All patients underwent respiratory management with IMV and circulatory management with catecholamine support as needed; enteral nutrition (20 kcal/kg/day) was performed by inserting an elemental diet tube. All patients were treated in the same manner except for NYT administration which was administered in a dose of 7.5 g daily via the elemental diet tube in some patients. Patients who received NYT were compared to those who did not receive NYT. We retrospectively examined the PNI, length of IMV, length of ICU stay, length of hospital stay, rate of tracheostomy, and mortality rate.

Statistical analysis was performed using SPSS 24 statistical software (SPSS Inc, Chicago, USA). The association between NYT and non-NYT was analyzed with the chi-square test, Fisher's exact test, and Mann-Whitney U test. A p value less than 0.05 was considered to be statistically significant.

Nine patients were enrolled in the study. The NYT group (4 patients who received NYT) and non-NYT group (5 patients who did not receive NYT) were compared.

The demographic and clinical characteristics of the patients are shown in Table 2 . The median age of the enrolled patients was 60.0 (42-84) years, with 4 (44%) men and 5

(56%) women. The median body mass index (BMI) was 27.6 (20.7-38.4). The most common comorbidity was diabetes (4 patients, 44%), followed by hypertension (3 patients, 33%), and chronic kidney disease (2 patients, 22%). J o u r n a l P r e -p r o o f Journal Pre-proof The median PNI at admission was 29.0 in NYT group and 31.2 in non-NYT group. One

week after admission, the PNI was 30.7 in the NYT group and 24.4 in non-NYT group.

Comparing the rate of increase/decrease at the time of admission and one week after admission, PNI was significantly (p=0.032) increased in the NYT group (+13.6%) compared to the non-NYT group (-22.0%).

Treatment of severe COVID-19 patients tends to be prolonged, and the increase in the number of patients requiring ICU support also causes major global social and economic disruption. Longer hospital stays lead to increased medical expenses. Although effective therapeutic drugs for COVID-19 are required, currently there is no effective and specific antiviral treatment for COVID-19. Based on available evidence, remdesivir and J o u r n a l P r e -p r o o f Journal Pre-proof dexamethasone have been used in Japan, but these drugs are not likely to be sufficient for successful treatment of COVID-19 (Sanders et al., 2020 ) (Beigel et al., 2020 Grein et al., 2020) .

In this study, we investigated the use of the Japanese Kampo medicine, NYT (see Kampo medicines are inexpensive. If the ICU stay period is shortened, the medical cost benefit will be enormous. We believe that NYT should be studied for COVID-19

treatment. This report is first study to use NYT for treatment of COVID-19 infection. (Table 1 ).

In COVID-19 patients, it is possible that NYT might improve respiratory symptoms, anxiety, nutritional status, and efficiency of rehabilitation. Especially in COVID-19 patients, NYT's antithrombotic effects and improvement of respiratory symptoms are important. Previous studies showed that Rehmannia root, Cinnamon bark, Peony Root, and Ginseng have antithrombotic effects (Matsuda, 1986; MATSUDA et al., 1987; MATSUDA et al., 1986; Sakuragawa, 1983) . Therefore, NYT might be useful in treating patients with severe COVID-19.

Moreover, NYT includes Schisandra fruit and polygala root. Schisandra fruit has been used to treat chronic cough as a prescription medication in traditional herbal medicine.

Schisandra chinensis fruit polysaccharide-1 (SCFP-1), extracted from Schisandra fruit, has antitussive activity (Zhong et al., 2016) . In addition, Gomisin A (G. A) is a dietary lignan compound from Schisandra chinensis. Gomisin suppressed colorectal lung metastasis in a lung metastasis mouse model by inducing AMPK/p38-mediated J o u r n a l P r e -p r o o f apoptosis (Kee et al., 2018) . NYT inhibited the contraction of guinea pig bronchial smooth muscle induced by histamine (Inoue, 1994) . In fact, NYT is an effective and promising drug with various effects in frail patients with chronic obstructive pulmonary disease, despite conventional treatment (Hirai et al., 2020) .

Polygala has been widely used to improve cognitive function. NYT improves mental stress-induced anxiety in neuropeptide Y-deficient zebrafish; Schisadorina fruit was identified as the compound responsible for the anxiolytic effect of NYT (Kawabe et al., 2021) .

NYT achieved good rehabilitation results in an elderly patient with hip fracture and sarcopenia; NYT improved nutritional status, such as the serum levels of retinol-binding protein and prealbumin, increased muscle mass, and improved amino acid metabolism and storage in the skeletal muscle (Morinaga et al., 2020) . Recently, NYT was considered to be a novel therapeutic option for the treatment of sarcopenia and frailty (Sakisaka et al., 2018; Uto et al., 2018) . Through the improvement of amino acid metabolism, NYT maintains skeletal muscle mass and might improve the loss of skeletal muscle function (Ohsawa et al., 2018) .

In this study, we evaluated nutritional status using PNI. PNI is easily calculated based on the serum albumin concentration and peripheral blood lymphocyte count (10 × serum albumin (g/dL) + 0.005 × total lymphocyte count (µL)), and is an indicator of the nutritional and immune status (Hong et al., 2015; Ikeya et al., 2015) . It has been confirmed to have prognostic value in various settings, such as infectious disease, cardiovascular disease, and various cancers (He et al., 2017; Keskin et al., 2017; Peng et al., 2017; Shirakabe et al., 2018; Sun et al., 2015; Wu et al., 2016) . Recently, several reports indicated that PNI is independently associated with mortality in COVID-19 patients, and a lower PNI score is associated with a worse prognosis. (Hu et al., 2021; Wang et al., 2020b; Wang et al., 2021; Wei et al., 2021) .

In this study, we compared the PNI at admission and after one week, PNI was significantly (p=0.032) increased in the NYT group (+13.6%) compared to the non-NYT group (-22.0%). All patients were treated in the same manner except for NYT administration. It is possible that PNI was improved by the administration of NYT from the elemental diet tube immediately after underwent respiratory management with IMV.

In addition, the NYT group had improved nutritional status and shorter length of IMV, length of ICU stay, and length of hospital stay.

This study was conducted in a small number of cases, and further large clinical trials are necessary to determine the efficacy of NYT treatment for COVID-19. In Japan, integrative randomized controlled trials of Japanese Kampo medicine for COVID-19 are underway (Namiki et al., 2021; Takayama et al., 2021; Takayama et al., 2020) .

Our study suggests that the Japanese Kampo medicine NYT might be useful for treating patients with severe COVID-19 in the ICU.

This study was performed in accordance with the Declaration of Helsinki and institutional guidelines. The patients/participants provided their written informed consent to participate in this study. The institutional ethics committee approval number is 2109066.

NA made a substantial contribution to the study conception, conducted a literature 

Compassionate use of remdesivir for patients with severe Covid-19

AKT-targeted anti-inflammatory activity of Panax ginseng calyx ethanolic extract

Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine

Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas

Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty

The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients

Effects of Glycyrrhiza glabra polysaccharides on immune and antioxidant activities in high-fat mice

Predictive value of the prognostic nutritional index for the severity of coronavirus disease 2019

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer

Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS

General Pharmacology of Ninjin-yoei-to(NIN) and Juzen-taiho-to(JUZ)

Huangqi): a well-known Chinese tonic

Inhibitory effect of oriental medicine

Anti-thrombic actions of 70% methanolic extract and cinnamic aldehyde from cinnamomi cortex

Pharmacological Study on Panax ginseng CA MEYER. III.: Effects of Red Ginseng on Experimental Disseminated Intravascular Coagulation

Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice

Multifunctional actions of ninjinyoeito, a Japanese Kampo medicine: accumulated scientific evidence based on experiments with cells and animal models, and clinical studies

Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report

Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California

Evaluation of the immunomodulatory properties in mice and in vitro anti-inflammatory activity of cycloartane type saponins from Astragalus species

A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)

Effect of ninjin'yoeito on the loss of skeletal muscle function in cancer-bearing mice

Treatment of insulin resistance with peroxisome proliferatoractivated receptor γ agonists

Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer

Another decade, another coronavirus

Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk

A clinical study of ninjin'yoeito with regard to frailty

Studies on the infuluences of Wakan-Yakus (traditional herbal drugs) on Blood Coagulation System

Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review

BT-11 improves stress-induced memory impairments through increment of glucose utilization and total neural cell adhesion molecule levels in rat brains

The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score

Metabolomics study of the therapeutic mechanism of Schisandra chinensis lignans on aging rats induced by d-galactose

Novel immunological and nutritional-based prognostic index for gastric cancer

Conventional and Kampo medicine in the treatment of mild to moderate COVID-19: A multicenter, retrospective observational study protocol by the Integrative Management in Japan for Epidemic Disease

A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage

Herbal medicine ninjin'yoeito in the treatment of sarcopenia and frailty

Antiinflammatory activity of constituents isolated from aerial part of Angelica acutiloba Kitagawa

Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Chemical and morphological variations of Panax notoginseng and their relationship

Determination and pharmacokinetic study of pachymic acid by LC-MS/MS

The Prognostic Nutritional Index is associated with mortality of COVID-19 patients in Wuhan

Predictive Value of Prognostic Nutritional Index on COVID-19 Severity

Predictive Significance of the Prognostic Nutritional Index (PNI)

Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

ATF-2/CREB/IRF-3-targeted anti-inflammatory activity of Korean red ginseng water extract

Chemical profile and anti-inflammatory activity of total flavonoids from glycyrrhiza uralensis fisch

Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide

A polysaccharide from the alkaline extract of Glycyrrhiza inflata induces apoptosis of human oral cancer SCC-25 cells via mitochondrial pathway

Pachymic acid, a novel compound for anti-rejection: Effect in rats following cardiac allograft transplantation

Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice

Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak

Antitussive activity of the Schisandra chinensis fruit polysaccharide (SCFP-1) in guinea pigs models

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study